Document is current

Any future updates will be listed below

Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse event reporting system reports

Crossref DOI link: https://doi.org/10.1007/s00277-026-06951-z

Published Online: 2026-04-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark